D-1120-2019 Class II Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-1120-2019 was initiated by Glenmark Pharmaceuticals Inc., USA on Mar 25, 2019 and is designated Class II. Reason for recall: Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg. The recall status is terminated (terminated Sep 14, 2020). Affected quantity: 2076 500-count Bottles.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2019
Initiation Date
Mar 25, 2019
Termination Date
Sep 14, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2076 500-count Bottles

Product description

Pravastatin Sodium Tablets USP, 20 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma zone SEZ, Pithampur, Dist-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. NDC 68462-196-05

Reason for recall

Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.

Distribution pattern

Nationwide in the USA

Code information

Lot 17181491 Exp. Aug. 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1120-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1120-2019. Report a data issue: hello@regdatalab.com.